Latest Financial Health News

Tasmea Limited has announced a fully franked ordinary dividend of AUD 0.06 per share for the six months ending June 2025, accompanied by a Dividend Reinvestment Plan offering a 5% discount on new shares.

DATA#3 Limited has announced a fully franked ordinary dividend of AUD 0.15 per share for the six months ending June 2025, signaling steady shareholder returns amid a stable financial period.

Bendigo and Adelaide Bank has announced a fully franked ordinary dividend of AUD 0.33 per share for the six months ending June 2025, with key dates set for early September and payment at the end of the month.

Praemium Limited reported robust FY25 results with revenue climbing 24.6% to $103 million and net profit after tax soaring 55% to $13.56 million, underpinned by strong growth in funds under administration and strategic product launches.

Embark Early Education announces a fully franked interim dividend alongside robust first-half financial results, highlighting significant revenue and profit gains.

Elsight Limited has reported a remarkable 344% jump in first-half revenue to US$4.85 million, significantly narrowing its net loss and securing a substantial US$39 million capital raise to fuel growth.

IMDEX Limited reported resilient FY25 earnings highlighted by a record fourth quarter revenue and significant progress in its digital growth strategy, supported by strategic acquisitions and strong operational performance.

Plato Income Maximiser Limited has reported a robust 29.9% increase in revenue and a 26.7% rise in profit after tax for the fiscal year ending June 2025, alongside consistent fully franked dividends.

My Foodie Box Ltd reported a net loss of $240,933 for FY25 following the divestment of its core meal kit business and is now pursuing a complex relisting on the ASX amid ongoing funding needs and going concern uncertainties.

Spheria Emerging Companies Limited has reported a remarkable doubling of both revenue and profit for the fiscal year ending June 2025, alongside increased fully franked dividends.

Cannindah Resources Limited has had its trading suspension lifted immediately following the release of a capital raising announcement, signaling renewed market activity.

Nyrada Inc. reported a sharp 25% decline in revenues alongside a 248% surge in net losses for the fiscal year ending June 2025, signaling mounting financial pressures for the pharmaceutical developer.